SAT0323 The endothelial-to-mesenchymal transition (ENDOMT) in scleroderma can be prevented by the use of dual endothelin receptor antagonists bosentan and macitentan [PDF]
Claudio Corallo +6 more
openalex +1 more source
ABSTRACT There is a limited understanding of how pulmonary hypertension (PH) patients are managed worldwide. The Pulmonary Vascular Research Institute (PVRI) Innovative Drug Discovery Initiative (IDDI) global survey attempted to obtain insights into access to PH care in diverse international regions to pave future action plans.
Sasha Z. Prisco +9 more
wiley +1 more source
Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase-5 Inhibitors (PDE5i). [PDF]
Kolaitis NA +10 more
europepmc +1 more source
ABSTRACT Pulmonary Langerhans cell histiocytosis (PLCH) frequently complicated by pulmonary hypertension (PH), which markedly worsens prognosis. We retrospectively reviewed three institutional PLCH‐PH cases treated with off‐label Sotatercept added to background triple therapy and performed a systematic review of published PLCH‐PH reports (PubMed/Embase
Giorgi Chilingarashvili +7 more
wiley +1 more source
Long-Term Administration of Endothelin Receptor Antagonist Improves Coronary Endothelial Function in Patients With Early Atherosclerosis [PDF]
Martin Reriani +9 more
openalex +1 more source
ABSTRACT Exercise testing has long been essential for evaluating diagnosis, prognosis, and functional status in pulmonary hypertension (PH). Recent advances have clarified its role in defining reference values and prognostic markers. Nonetheless, substantial knowledge gaps persist regarding the implementation of invasive cardiopulmonary exercise ...
Aaron B. Waxman +20 more
wiley +1 more source
The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney disease. [PDF]
Smeijer JD +3 more
europepmc +1 more source
MP44-13 EFFECTS OF THE RECEPTOR ANTAGONIST PICOTAMIDE ON ENDOTHELIN-1-, -2- AND -3-INDUCED CONTRACTIONS IN HUMAN PROSTATE SMOOTH MUSCLE [PDF]
Alexander Tamalunas +5 more
openalex +1 more source

